Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lenumlostat is an orally available, selective and potent lysyl oxidase-like protein 2 (LOXL2) inhibitor with inhibitory effects on hLOXL2, hLOXL3 and LOXL2 for the study of fibrotic diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $197 | In Stock | |
5 mg | $497 | In Stock | |
10 mg | $747 | In Stock | |
25 mg | $1,490 | In Stock | |
50 mg | $2,320 | In Stock | |
100 mg | $3,320 | In Stock | |
500 mg | $6,670 | In Stock | |
1 mL x 10 mM (in DMSO) | $547 | In Stock |
Description | Lenumlostat is an orally available, selective and potent lysyl oxidase-like protein 2 (LOXL2) inhibitor with inhibitory effects on hLOXL2, hLOXL3 and LOXL2 for the study of fibrotic diseases. |
Targets&IC50 | LOXL2:0.10 μM (Mouse), LOXL3 (human):1.17 μM, LOXL2 (human):0.71 μM, LOXL2:0.12 μM (Rat), LOXL2:0.16 μM (Dog) |
In vitro | Lenumlostat(PAT-1251)is a Lysyl Oxidase-Like 2 (LOXL2) inhibitor, with IC50s of 0.71 μM and 1.17 μM for hLOXL2 and hLOXL3, respectively. It also potently inhibits LOXL2 in mouse, rat, and dog, with IC50s of 0.10 μM, 0.12 μM, and 0.16 μM, respectively. Lenumlostat(PAT-1251) exhibits high selectivity for LOXL2 over other key members of the amine oxidase family, such as the copper-dependent amine oxidases semicarbazide-sensitive amine oxidase (SSAO) and diamine oxidase (DAO). Additionally, it shows selectivity against the flavin-dependent monoamine oxidases A (MAO-A) and B (MAO-B), with less than 10% inhibition at 10 μM[1]. |
Alias | PAT-1251, GB2064 |
Molecular Weight | 399.34 |
Formula | C18H17F4N3O3 |
Cas No. | 2098884-52-5 |
Smiles | O(C=1N=C(C(F)(F)F)C=C(CN)C1)C2=CC(C(=O)N3C[C@@H](F)[C@H](O)C3)=CC=C2 |
Storage | store under nitrogen | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45 mg/mL (112.69 mM), Sonication is recommended. H2O: 80 mg/mL (200.33 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.